Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04ZEY
|
||||
| Former ID |
DNC000513
|
||||
| Drug Name |
DADMe-ImmH
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [535759] | ||
| Formula |
C21H27N3O7
|
||||
| Canonical SMILES |
CN1C2CC3C1C4C(C5=C(C(N4C2O)CO)C(=O)C(=C(C5=O)OC)OC)N6C3<br />OCC6
|
||||
| InChI |
1S/C21H27N3O7/c1-22-9-6-8-13(22)15-14(23-4-5-31-21(8)23)12-11(10(7-25)24(15)20(9)28)16(26)18(29-2)19(30-3)17(12)27/h8-10,13-15,20-21,25,28H,4-7H2,1-3H3/t8?,9?,10-,13?,14?,15?,20-,21?/m1/s1
|
||||
| InChIKey |
VLKRTIYDCRKNTE-ZNSCMWNVSA-N
|
||||
| CAS Number |
CAS 62046-87-1
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Purine nucleoside phosphorylase | Target Info | Inhibitor | [535759] | |
| BioCyc Pathway | Arsenate detoxification I (glutaredoxin) | ||||
| Purine nucleotides degradation | |||||
| Urate biosynthesis/inosine 5'-phosphate degradation | |||||
| Purine deoxyribonucleosides degradation | |||||
| Purine ribonucleosides degradation to ribose-1-phosphate | |||||
| Guanosine nucleotides degradation | |||||
| Adenosine nucleotides degradation | |||||
| Superpathway of purine nucleotide salvage | |||||
| Adenine and adenosine salvage III | |||||
| Guanine and guanosine salvage | |||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| EGFR1 Signaling Pathway | |||||
| PathWhiz Pathway | Purine Metabolism | ||||
| Nicotinate and Nicotinamide Metabolism | |||||
| Reactome | Purine salvage | ||||
| Purine catabolism | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.